show episodes
 
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
 
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
 
This program provides people diagnosed with multiple myeloma - as well as their caregivers, family, and friends - with practical tools you can use in your daily life as you deal with your cancer diagnosis and treatment.
 
Myeloma Crowd Radio brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
 
C
CureTalks
Monthly
 
CureTalks features leading medical experts in conversation with a panel of patients/advocates about latest research and treatments under development.
 
Loading …
show series
 
You may have seen today's guest reporting the weather on WABC-TV's Eyewitness News Saturday and Sunday Morning, possibly while running the TCS New York City Marathon, her name, Amy Freeze. Amy is an Emmy-Award Winning Meteorologist, Endurance Athlete, Runner, and also the Mother of four athletic and talented children. She does it all! Marni and ...…
 
Dr. Jonathan Keats discusses how multiple myeloma can be multiple cancers from a genetic standpoint. Through his work with the Multiple Myeloma Research Foundation's CoMMpass Study, Dr. Keats' team has sequenced 1,150 patients from 90 sites worldwide. What does this mean for patients?
 
* Overview of Blood Cancers* New Research Presented at ASH* Disease-Specific Treatment Updates: Leukemia, Myeloproliferative Neoplasms (MPN), Lymphoma, Multiple Myeloma* The Role of Personalized Medicine and Clinical Trials* Talking with Your Health Care Team about Your Treatment Options* Quality-of-Life Concerns and Goals of Care* Questions fo ...…
 
* Overview of Blood Cancers* New Research Presented at ASH* Disease-Specific Treatment Updates: Leukemia, Myeloproliferative Neoplasms (MPN), Lymphoma, Multiple Myeloma* The Role of Personalized Medicine and Clinical Trials* Talking with Your Health Care Team about Your Treatment Options* Quality-of-Life Concerns and Goals of Care* Questions fo ...…
 
Deana Chiusano was 39 years old when she was diagnosed with multiple myeloma in April 2011. She sought the most effective treatment for her specific type of cancer that led her to Winship Cancer Institute of Emory University - the state of Georgia's only National Cancer Institute (NCI) designated comprehensive cancer center. A cancer discovery ...…
 
Fourth year student-pharmacist Tola Adebanjo shares her journey through application-based APPEs at Johns Hopkins Hospital in the Clinical Track Student Pharmacist Program, as an APhA Experiential Program Intern, and how she approached the Residency Showcase at ASHP in Orlando. She also outlines the benefits of the three-year PharmD at the Unive ...…
 
This is a very exciting time for multiple myeloma (MM) research, with advances in a range of areas from new endpoints, to novel therapies and imaging. In this video, an overview of these updates are given by Gareth Morgan, MD, FRCP, FRCPath, PhD of UAMS Myeloma Institute, Little Rock, AR, Nina Shah, MD of UCSF Medical Center, San Francisco, CA ...…
 
Fantastic advances in immunotherapy, including CAR T-cells, bispecific antibodies and potential immunotherapy combinations, were presented at the Myeloma 2017 meeting in Edinburgh, UK. In this panel discussion, Keith Stewart, MB, ChB and Leif Bergsagel, MD from the Mayo Clinic, Scottsdale, AZ and Gareth Morgan, MD, FRCP, FRCPath, PhD of UAMS My ...…
 
The highly anticipated panel discussion on the hot topic of MRD at the Myeloma 2017 meeting in Edinburgh, UK produced thought-provoking debate. In this video the main points of debate are discussed by Jeffrey Wolf, MD from the University of California, San Francisco, CA, Roger Owen, MD, MRCP, MRCPath of Leeds Teaching Hospitals NHS Trust, Leeds ...…
 
Guest: Parameswaran Hari, MD Guest: Nina Shah, MD In the age of immunomodulatory agents, proteasome inhibitors, and other novel agents for the treatment of multiple myeloma (MM), the role of autologous hematopoietic stem cell transplantation (ASCT) has become an area of debate. Whereas most oncologists recognize a role for ASCT in the up-front ...…
 
Guest: Parameswaran Hari, MD Guest: Nina Shah, MD In the age of immunomodulatory agents, proteasome inhibitors, and other novel agents for the treatment of multiple myeloma (MM), the role of autologous hematopoietic stem cell transplantation (ASCT) has become an area of debate. Whereas most oncologists recognize a role for ASCT in the up-front ...…
 
Scott was diagnosed with multiple myeloma in December 2012 after suffering through terrible bone and back pain for more than a year. Scott immediately sought a second opinion from Dana-Farber. Patients’ reviews and research indicated that Dr. Anderson is the “best in the business” and that Dana-Farber is a leader in multiple myeloma. At Dana-Fa ...…
 
Ryan Anthony is the principal trumpet with the Dallas Symphony Orchestra and founder of a Cancer Blows, an annual concert series featuring the world’s top trumpeters to raise funds and awareness towards finding a cure for multiple myeloma, which he was diagnosed with in 2013. JN: Ryan, get us up to speed. What’s going on… The post Ryan Anthony ...…
 
Integrating Novel Agents Into Treatment of Relapsed/Refractory Multiple Myeloma: Addressing Current Challenges and Unmet Needs in Brazil
 
In this week's episode we sit down with Gina Estrada. Gina is a person that doesn't let life take control. She is strong willed, religious and a go getter. She didn't let multiple myeloma stop her. Discover her story and how she survived. Can we learn anything? Lets find out.
 
The MMRF has built a unique model that provides the only end-to-end solution in cancer research. This model is based on three interrelated pillars fueled by data generation and integration; collaboration and discovery; and accelerating clinical trials. Integrating this model with precision medicine, MMRF aims to get closer to finding a cure for ...…
 
* Overview and Definition of Generic Drugs* The Difference Between Generic Drugs and Brand Name Drugs* Are Generic Drugs as Effective as Brand-Name Drugs in Cancer Treatment?* Managing the Costs of Treatment with Generic Drugs* How are Generic Drugs Approved?* The Difference Between Generic Drugs and Biosimilars* The Role of Clinical Trials* Th ...…
 
Listen as Dr. Niesvizky discusses the most common cause of renal failure in newly diagnosed patients with MM.
 
When Linda Solomon, a trained medical technologist, saw the results of her routine complete blood count in 2009, she knew it wasn’t good news. Solomon, then 61, was diagnosed with stage III multiple myeloma – and given three years to survive. Several rounds of chemotherapy, two stem cell transplants, and eight years later, Solomon is still here ...…
 
Proceedings from a Clinical Investigator Roundtable Discussion with Rafael Fonseca, MD and Noopur Raje, MD. Moderated by Neil Love, MD. Produced by Research To Practice.
 
* Overview of Cancer Treatments* Definition of Adherence: Taking Your Pills on Schedule* The Important Role of Adherence in Treating Cancer* Barriers to Taking Your Pills* Practical Tips to Overcome These Barriers, including Family, Partners and Others* Computer, Tablet and Phone Reminders including Emails, Texts and Apps* Planning Ahead: Lead ...…
 
Bloomberg Markets with Carol Massar and Cory Johnson.GUESTS:Dani BurgerStocks ReporterBloomberg NewsDiscussing her story "For Quants, Megacap Tech Rout Looks Like a Systematic Unwind."David WilsonStocks EditorBloomberg NewsDiscussing his "Stock of the Day"Bluebird Bio (BLUE). Bluebird Bio Inc.'s shares fell for the first time in eight days afte ...…
 
Bloomberg Markets with Carol Massar and Cory Johnson.GUESTS:Dani BurgerStocks ReporterBloomberg NewsDiscussing her story "For Quants, Megacap Tech Rout Looks Like a Systematic Unwind."David WilsonStocks EditorBloomberg NewsDiscussing his "Stock of the Day"Bluebird Bio (BLUE). Bluebird Bio Inc.'s shares fell for the first time in eight days afte ...…
 
Bloomberg Markets with Carol Massar and Cory Johnson.GUESTS:Dani BurgerStocks ReporterBloomberg NewsDiscussing her story "For Quants, Megacap Tech Rout Looks Like a Systematic Unwind."David WilsonStocks EditorBloomberg NewsDiscussing his "Stock of the Day"Bluebird Bio (BLUE). Bluebird Bio Inc.'s shares fell for the first time in eight days afte ...…
 
* Overview of Transplantation, including Types of Transplantation* Transplantation as a Treatment Option for Multiple Myeloma* General Guidelines for Transplantation* Searching for a Donor* Follow-Up Care* Practical Tips to Manage Post-Treatment Concerns, including Graft vs. Host Disease* The Important Role of Clinical Trials* Communicating wit ...…
 
* Overview of Transplantation, including Types of Transplantation* Transplantation as a Treatment Option for Multiple Myeloma* General Guidelines for Transplantation* Searching for a Donor* Follow-Up Care* Practical Tips to Manage Post-Treatment Concerns, including Graft vs. Host Disease* The Important Role of Clinical Trials* Communicating wit ...…
 
On Heels on American Society of Clinical OncologyAnnual Meeting (June 2-6) a Look at Latest Advances in Cancer Research and an Inspiring Story The annual meeting of the American Society of Clinical Oncology (ASCO), the largest global cancer conference of the year, brings together the worldâ??s leading cancer researchers to share the latest rese ...…
 
In 2016 Craig Faulkner was diagnosed with Multiple Myeloma, a type of blood cancer that, once rare, has a growing number of incidents. In this first podcast he summarizes the first 9 months of his illness and tells others what to expect if they too receive a diagnosis.
 
* Why Some Chemotherapy Agents Cause Nausea and Vomiting* How Health Care Teams Approach Prevention of Nausea and Vomiting* Prevention Strategies* The Role of the Oncology Nurse in Preventing Side Effects* Current Research Directions to Improve Control of Nausea and Vomiting* New Agents* The Importance of Clinical Trials* Communicating with You ...…
 
JOHN 14:15-21 A great New Testament scholar of the last century, Krister Stendahl, a Swedish Lutheran bishop, developed what he called “The Ten Commandments for Biblical Preaching.” I’ve never been able to find the entire list, but I’ve heard a number of them, and they’ve stuck with me. One was that, as a preacher, you are not responsible for w ...…
 
* Overview of Multiple Myeloma* Current Standard of Care, New Treatment Approaches and the Role of Transplantation* Clinical Trials: How Research Contributes to Your Treatment Options* Practical Tips for Symptom and Pain Management* Reducing Complications of Bone Disease* Physical Activity Concerns, Tips and Guidelines* Communicating with Your ...…
 
* Overview of Multiple Myeloma* Current Standard of Care, New Treatment Approaches and the Role of Transplantation* Clinical Trials: How Research Contributes to Your Treatment Options* Practical Tips for Symptom and Pain Management* Reducing Complications of Bone Disease* Physical Activity Concerns, Tips and Guidelines* Communicating with Your ...…
 
Listen as Dr. Richter discusses when you need to do a bone marrow biopsy in the management or assessment of multiple myeloma.
 
Google login Twitter login Classic login